Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
揭示 MYC 驱动肿瘤中脂肪酸氧化的调节和依赖性机制
基本信息
- 批准号:10436804
- 负责人:
- 金额:$ 36.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-03 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acetyl Coenzyme AAcetyl-CoA CarboxylaseAcyl Coenzyme AAdipocytesAdipose tissueAnimal ModelAutomobile DrivingBackBreastBreast Cancer ModelCancer ModelCarnitineCarnitine Palmitoyltransferase ICatabolismCell DeathCell membraneCellsCitric Acid CycleCombined Modality TherapyCytosolDependenceDevelopmentDistantDrug TargetingEnergy-Generating ResourcesEnzymesEquilibriumFatty AcidsGrowthHead CancerHumanHuman Cell LineLeadLipolysisLymphomaMYC geneMaintenanceMalignant Childhood NeoplasmMalignant NeoplasmsMalignant neoplasm of liverMalonyl Coenzyme AMediatingMediator of activation proteinMetabolicMetabolic PathwayMetabolismMitochondriaMitochondrial MatrixMolecularNeck CancerNeoplasm MetastasisOuter Mitochondrial MembranePathway interactionsPatient-derived xenograft models of breast cancerProcessProductionRegulationResearchSiteTestingTherapeuticTissuesTransgenic AnimalsTransgenic ModelTransgenic Organismsacylcarnitineaggressive breast cancerbasecancer typedrug testingetomoxirfatty acid oxidationfatty acid transportfatty acid-binding proteinsfatty acid-transport proteinimprovedin vivoinhibitorinnovationlong chain fatty acidmalignant breast neoplasmmalignant stateneoplastic cellnew therapeutic targetnovelnovel therapeuticsoverexpressionoxidationpatient derived xenograft modelpreclinical studyprogramsreceptorresponsesmall moleculesmall molecule inhibitortranslocasetreatment responsetriple-negative invasive breast carcinomatumortumor growthtumor metabolismtumor microenvironment
项目摘要
Project Summary
The MYC oncogene is overexpressed in some of the most aggressive and difficult to treat human cancers,
including receptor triple-negative breast cancers (TNBCs), as well as high-grade lymphomas and aggressive
subtypes of liver cancers. MYC overexpression induces a highly malignant state by driving proliferation and
altering various metabolic programs within tumor cells. We recently discovered that MYC-driven transgenic
models of breast cancer have reprogramed cellular metabolism that favor fatty acid oxidation (FAO) as an
energy source. This finding was also observed in MYC-high TNBCs and has recently been confirmed by an
independent research group. Targeting FAO in human cell lines, MYC-driven transgenic animal models and
patient-derived xenograft (PDX) models of breast cancer results in diminished tumor growth and increased cell
death. What remains unknown is what are the molecular mechanisms through which MYC reprograms tumor
metabolism to favor FAO. Furthermore, we seek to understand why MYC-high tumors are dependent on the
FAO pathway for their growth and survival. Finally, we seek to improve upon current therapies for TNBCs by
performing advance preclinical studies in PDX models to determine if blocking FAO alone or in combination
with other metabolic pathways in vivo will provide improved therapeutic response. Our studies will improve our
understanding of how MYC reprograms metabolism in vivo and will lead to novel therapeutics for difficult to
treat MYC overexpressing cancers.
项目总结
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.
- DOI:10.1186/s13058-022-01540-0
- 发表时间:2022-09-24
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
In Vivo Optical Metabolic Imaging of Long-Chain Fatty Acid Uptake in Orthotopic Models of Triple-Negative Breast Cancer.
- DOI:10.3390/cancers13010148
- 发表时间:2021-01-05
- 期刊:
- 影响因子:5.2
- 作者:Madonna MC;Duer JE;Lee JV;Williams J;Avsaroglu B;Zhu C;Deutsch R;Wang R;Crouch BT;Hirschey MD;Goga A;Ramanujam N
- 通讯作者:Ramanujam N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREI GOGA其他文献
ANDREI GOGA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREI GOGA', 18)}}的其他基金
Understanding CDK1 Function and Cancer Vulnerabilities
了解 CDK1 功能和癌症脆弱性
- 批准号:
10736617 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization
将乳腺癌进展理解为组织自组织机制的缺陷
- 批准号:
10395995 - 财政年份:2020
- 资助金额:
$ 36.2万 - 项目类别:
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization
将乳腺癌进展理解为组织自组织机制的缺陷
- 批准号:
10613917 - 财政年份:2020
- 资助金额:
$ 36.2万 - 项目类别:
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
揭示 MYC 驱动肿瘤中脂肪酸氧化的调节和依赖性机制
- 批准号:
10194413 - 财政年份:2018
- 资助金额:
$ 36.2万 - 项目类别:
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
体内代谢灾难是由急性癌基因抑制(PQ
- 批准号:
8676483 - 财政年份:2012
- 资助金额:
$ 36.2万 - 项目类别:
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
体内代谢灾难是由急性癌基因抑制(PQ
- 批准号:
8384577 - 财政年份:2012
- 资助金额:
$ 36.2万 - 项目类别:
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
体内代谢灾难是由急性癌基因抑制(PQ
- 批准号:
8513950 - 财政年份:2012
- 资助金额:
$ 36.2万 - 项目类别:
Targeting the MYC Oncogene with CDK Inhibitors
使用 CDK 抑制剂靶向 MYC 癌基因
- 批准号:
8641666 - 财政年份:2010
- 资助金额:
$ 36.2万 - 项目类别:
Targeting the MYC Oncogene with CDK Inhibitors
使用 CDK 抑制剂靶向 MYC 癌基因
- 批准号:
7890072 - 财政年份:2010
- 资助金额:
$ 36.2万 - 项目类别:
相似海外基金
Acetyl CoA Carboxylase in the Metabolic Control of Inflammation
乙酰辅酶A羧化酶在炎症代谢控制中的作用
- 批准号:
10660439 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Role of Acetyl CoA carboxylase in type 2 diabetic kidney disease
乙酰辅酶A羧化酶在2型糖尿病肾病中的作用
- 批准号:
10252084 - 财政年份:2020
- 资助金额:
$ 36.2万 - 项目类别:
The role of acetyl-CoA carboxylase enzymes in fatty liver disease and cancer
乙酰辅酶A羧化酶在脂肪肝疾病和癌症中的作用
- 批准号:
nhmrc : GNT1163903 - 财政年份:2019
- 资助金额:
$ 36.2万 - 项目类别:
Project Grants
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
肝乙酰辅酶 A 羧化酶抑制对 NAFLD 和肝胰岛素抵抗的影响
- 批准号:
9763549 - 财政年份:2017
- 资助金额:
$ 36.2万 - 项目类别:
Effect of Liver-Specific Acetyl-CoA Carboxylase Inhibition on Hepatic Steatosis and Insulin Resistance
肝脏特异性乙酰辅酶A羧化酶抑制对肝脏脂肪变性和胰岛素抵抗的影响
- 批准号:
9467827 - 财政年份:2017
- 资助金额:
$ 36.2万 - 项目类别:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
肝乙酰辅酶 A 羧化酶抑制对 NAFLD 和肝胰岛素抵抗的影响
- 批准号:
9361162 - 财政年份:2017
- 资助金额:
$ 36.2万 - 项目类别:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
肝乙酰辅酶 A 羧化酶抑制对 NAFLD 和肝胰岛素抵抗的影响
- 批准号:
10217114 - 财政年份:2017
- 资助金额:
$ 36.2万 - 项目类别:
Elucidation of activation mechanism of human acetyl-CoA carboxylase
阐明人乙酰辅酶A羧化酶的激活机制
- 批准号:
22590113 - 财政年份:2010
- 资助金额:
$ 36.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Duel Functions of Acetyl-CoA Carboxylase
乙酰辅酶A羧化酶的双重功能
- 批准号:
0841143 - 财政年份:2009
- 资助金额:
$ 36.2万 - 项目类别:
Continuing Grant
Protein complex formation in the regulation and polymerization fo acetyl-coa carboxylase
乙酰辅酶A羧化酶的调节和聚合中蛋白质复合物的形成
- 批准号:
348836-2007 - 财政年份:2008
- 资助金额:
$ 36.2万 - 项目类别:
Postgraduate Scholarships - Doctoral














{{item.name}}会员




